Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC
人群调整后的瑞波替尼在ROS1阳性非小细胞肺癌患者中的间接治疗比较
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050748
Wolf, Jürgen; Goring, Sarah; Lee, Adam; Cho, Byoung Chul; Drilon, Alexander; Yuan, Yong; Ayers, Dieter; Lozano-Ortega, Greta; Korol, Ellen E; Korpach, Sarah G; Crabtree, Madeleine; Huria, Lavanya; Calvet, Christophe Y; Camidge, D Ross
